Welcome to our dedicated page for Inspira Technologies Oxy Bhn news (Ticker: IINN), a resource for investors and traders seeking the latest updates and insights on Inspira Technologies Oxy Bhn stock.
Inspira Technologies Oxy B.H.N. Ltd. reports developments in Additively Manufactured Electronics, quantum connectivity and its medical technology portfolio. Company updates focus on AME system orders and deployments, QTREX-branded cryogenic interconnect work for superconducting quantum systems, customer activity with research, defense and technology organizations, and leadership or strategic-direction announcements.
The company's medical technology context includes respiratory support and blood monitoring platforms, including INSPIRA ART, INSPIRA ART100 and the HYLA Blood Sensor, while recent communications emphasize a dedicated medical business unit alongside the AME and quantum connectivity strategy.
QTREX Quantum (Nasdaq: QTEX) announced that its CEO Dagi Ben-Noon, Chairman Tal Parnas and senior management intend to use personal funds to purchase up to 2,000,000 ordinary shares over the next 12 months starting June 22, 2026.
Purchases, mainly via open-market transactions, will begin after financial results for the period ending June 30, 2026 and will follow insider trading rules. QTREX continues to advance its AME-based quantum connectivity strategy and plans to update shareholders on material milestones.
QTREX Quantum (Nasdaq: QTEX) announced a key milestone in quantum computing infrastructure, producing a cryogenic chip carrier using its proprietary single-build Additively Manufactured Electronics (AME) process. The design was supplied by a major U.S.-based quantum technology company.
The carrier extends QTREX’s AME platform into the processor-interface layer, integrating chip carrier and interconnect into one monolithic, Kapton-class polyimide architecture optimized for very low temperatures. This approach targets higher routing density, integrated shielding, fewer connector transitions and improved scalability for high-channel-count quantum processors.
QTREX Quantum (Nasdaq: QTEX) reported that one of the largest U.S.-based interconnect manufacturers has moved its AME system from development to the production floor after extensive validation.
The AME-enabled process achieved a 97% yield across hundreds of evaluations, marking a key milestone for high-density interconnect manufacturing for advanced electronics and quantum computing infrastructure.
QTREX Quantum (Nasdaq: QTEX) received an approximately $1 million grant from the Israel Innovation Authority to develop a native RF dielectric material for superconducting quantum computing connectivity.
The program focuses on high-density, low-loss RF signal routing inside cryogenic environments, targeting connectivity bottlenecks as quantum processors scale.
QTREX Quantum (Nasdaq:IINN) will present functional AME-based monolithic connectivity components for quantum computing systems at Quantum.Tech World 2026 in Boston on June 25–26, 2026.
The company will hold private, invitation-only meetings showcasing components addressing cryogenic interconnect challenges in superconducting quantum systems.
QTREX Quantum (Nasdaq: QTEX) received a purchase order from a U.S.-based Fortune 500 multinational for an Additively Manufactured Electronics (AME) system and related materials. The system, destined for a non-U.S. site, adds a global enterprise to QTREX’s AME customer base.
The AME platform is designed to create intricate structures with advanced materials in a single workflow, targeting complexity limits of conventional manufacturing and quantum connectivity. The order is expected to contribute to upcoming financial results and, together with recent orders, supports a commercial revenue base that, according to QTREX, already exceeds the most recently reported annual revenues of certain publicly traded quantum computing companies.
QTREX Quantum (Nasdaq: QTEX) priced a $10 million private placement of 6,666,667 ordinary shares (or equivalents) with a new institutional investor. Closing is expected around June 1, 2026, with net proceeds earmarked for working capital, corporate purposes, commercialization of AME-based cryogenic interconnects, and R&D.
QTREX Quantum (Nasdaq:IINN) is in advanced talks with a top-five global quantum computing company on a potential strategic collaboration. Both sides are running a joint technical evaluation of QTREX’s AME-based cryogenic interconnects within the partner’s refrigerator architecture.
If a definitive agreement is signed, the partner could adopt QTREX’s platform as its foundational cryogenic interconnect technology, embedding QTREX as a critical supplier across its future quantum hardware roadmap and aligning QTREX’s revenue prospects with the partner’s global deployment growth.
Inspira Technologies (Nasdaq: IINN) will change its corporate name to QTREX Quantum and begin trading under the new Nasdaq ticker QTEX on May 20, 2026. Warrants will trade as QTEXW. No shareholder action is required.
The new name highlights a strategic focus on its Additively Manufactured Electronics (AME) platform for advanced manufacturing, high‑performance electronics and quantum connectivity, targeting quantum computing connectivity inside dilution cryostats.
Inspira Technologies (Nasdaq:IINN) announced a $580,000 purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems, following a multi-patient hospital evaluation of more than 30 cases.
The order will be fulfilled immediately and serves as a key reference within Inspira’s ongoing strategic process for ART100 and related assets.